Phathom Pharmaceuticals, Inc.PHATNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank87
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
29.44%
↑ 113% vs avg
Percentile
P87
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-225.40%
Historical baseline
PeriodValue
Q4 202529.44%
Q3 202560.46%
Q2 202519.62%
Q1 2025-26.68%
Q4 202413.00%
Q3 20246.42%
Q2 2024-10.37%
Q1 2024-4.13%
Q4 2023-84.00%
Q3 2023-5.56%
Q2 2023-8.33%
Q1 202331.31%
Q4 2022-7.74%
Q3 2022-0.34%
Q2 2022-25.22%
Q1 2022-13.51%
Q4 20212.28%
Q3 2021-0.30%
Q2 2021-4.90%
Q1 202135.14%
Q4 2020-57.52%
Q3 2020-61.63%
Q2 2020-4.77%
Q1 202079.45%
Q4 2019-43.89%
Q3 201922.39%
Q2 2019-6915.35%
Q1 2019-158.47%
Q4 2018-66.90%
Q3 2018-12.84%
Q2 20180.00%
Q1 20180.00%